SusannaAntoniaMcColleyMD

PubMed

• A skin-interfaced, miniaturized platform for triggered induction, capture and colorimetric multicomponent analysis of microliter volumes of sweat.
  Joohee Kim, Seyong Oh, Da Som Yang, Larissa Rugg, Radhika Mathur, Sung Soo Kwak, Seonggwang Yoo, Shupeng Li, Evangelos E Kanatzidis, Geumbee Lee, Hong-Joon Yoon, Yongg...> ;Biosensors & Bioelectronics. 2024 Jun 1
• Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis.
  Paul McNally, Alvin Singh, Jane C Davies, Mark Higgins, Meng Liu, Jennifer Lu, Violeta Rodriguez-Romero, Judy L Shih, , Susanna A McColley, Margaret Rosenfeld> ;Journal of Cystic Fibrosis. 2024 Apr 4
• ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis.
  Francis J Gilchrist, Stephanie Bui, Silvia Gartner, Susanna A McColley, Harm Tiddens, Gary Ruiz, Florian Stehling, Muhsen Alani, Oksana Gurtovaya, Mark Bresnik, Timoth...> ;Journal of Cystic Fibrosis. 2024 Jan 1
• 2 citations
  Late Diagnosis in the Era of Universal Newborn Screening Negatively Affects Short- and Long-Term Growth and Health Outcomes in Infants with Cystic Fibrosis.
  Stacey L Martiniano, Runyu Wu, Philip M Farrell, Clement L Ren, Marci K Sontag, Alexander Elbert, Susanna A McColley> ;The Journal of Pediatrics. 2023 Nov 1
• 7 citations
  Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least OneAllele: A Phase 3, Open-Label Clinical...
  Claire Wainwright, Susanna A McColley, Paul McNally, Michael Powers, Felix Ratjen, Jonathan H Rayment, George Retsch-Bogart, Erica Roesch, Neil Ahluwalia, Anna Chin, C...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Jul 1
• 26 citations
  Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least OneAllele.
  Jennifer L Goralski, Jordana E Hoppe, Marcus A Mall, Susanna A McColley, Edward McKone, Bonnie Ramsey, Jonathan H Rayment, Phil Robinson, Florian Stehling, Jennifer L ...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Jul 1
• 1 citations
  Barriers and facilitators to recruitment of underrepresented research participants: Perspectives of clinical research coordinators.
  Marie E Heffernan, Leo Barrera, Zecilly R Guzman, Emily Golbeck, Aneta M Jedraszko, P Toddie Hays, Keith A Herzog, Richard T D'Aquila, Michael G Ison, Susanna A McColley> ;Journal of Clinical and Translational Science. 2023 Jan 1
• 19 citations
  Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening.
  Susanna A McColley, Stacey L Martiniano, Clement L Ren, Marci K Sontag, Karen Rychlik, Lauren Balmert, Alexander Elbert, Runyu Wu, Philip M Farrell> ;Journal of Cystic Fibrosis. 2023 Jan 1
• 1 citations
  Anti-racist strategies for clinical and translational research: Design, implementation, and lessons learned from a new course.
  Nia J Heard-Garris, Jen F Brown, Uchenna C Ewulonu, Mita S Goel, Adam S Gordon, Candace Henley, Sadiya S Khan, Shawn M Smith, Susanna A McColley> ;Journal of Clinical and Translational Science. 2023 Jan 1
• 7 citations
  Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 ...
  Madison N LeCroy, Lindsey N Potter, Karen Bandeen-Roche, Monica E Bianco, Anne R Cappola, Ebony B Carter, Peter S Dayan, Elizabeth Eckstrom, Dorothy F Edwards, Sarah S...> ;Journal of Clinical and Translational Science. 2023 Jan 1
• 16 citations
  Detection of disease-causing CFTR variants in state newborn screening programs.
  Meghan E McGarry, Clement L Ren, Runyu Wu, Philip M Farrell, Susanna A McColley> ;Pediatric Pulmonology. 2023 Feb 1
• 2 citations
  In response to "who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies".
  Meghan E McGarry, Susanna A McColley, Jennifer Taylor-Cousar> ;Respiratory Medicine. 2022 Oct 1
• Editor's response to "An oversight regarding the club cell?"
  Susanna A McColley> ;Pediatric Pulmonology. 2022 Sep 1
• 11 citations
  A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for.
  Jonathan H Rayment, Fadi Asfour, Margaret Rosenfeld, Mark Higgins, Lingyun Liu, Molly Mascia, Hildegarde Paz-Diaz, Simon Tian, Rachel Zahigian, Susanna A McColley> ;American Journal of Respiratory and Critical Care Medicine. 2022 Nov 15
• 5 citations
  Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States.
  Marci K Sontag, Joshua I Miller, Sarah McKasson, Amy Gaviglio, Stacey L Martiniano, Rhonda West, Marisol Vazquez, Clement L Ren, Philip M Farrell, Susanna A McColley, ...> ;International Journal of Neonatal Screening. 2022 Jun 23
• Pediatric Cardiopulmonary Exercise Testing: Interoperability Through Domain Analysis Modeling and a National Survey.
  Dan M Cooper, Ronen Bar-Yoseph, Robert I Liem, Thomas G Keens, Susanna A McColley, Shlomit Radom-Aizik> ;Medicine and Science in Sports and Exercise. 2022 May 1
• 1 citations
  A rare case of pancytopenia in a child with cystic fibrosis: Can copper cure it all?
  Maggie D. Seblani, Susanna A. McColley, Shunyou Gong, Lee M. Bass, Sherif M. Badawy> ;Pediatric Pulmonology. 2021 Sep 28
• 13 citations
  Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study.
  Stacey L. Martiniano, Alexander Elbert, Philip M. Farrell, Clement L. Ren, Marci K. Sontag, Runyu Wu, Susanna A. McColley> ;Pediatric Pulmonology. 2021 Sep 13
• Pancytopenia in a child with cystic fibrosis and severe copper deficiency: Insight from bone marrow evaluation.
  Maggie D. Seblani, Susanna A. McColley, Shunyou Gong, Lee M. Bass, Sherif M. Badawy> ;Pediatric Blood & Cancer. 2021 Jul 31
• 2 citations
  Comment on Munck et al., Feb, 2021.
  Marci K. Sontag, Phillip M. Farrell, Yvonne Kellar-Guenther, Stacey L. Martiniano, Joshua I. Miller, Clement L. Ren, Susanna A. McColley> ;Journal of Cystic Fibrosis. 2021 May 18
• 22 citations
  Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, ...
  Jordana E. Hoppe, Mark A. Chilvers, Felix Ratjen, John McNamara, Caroline A. Owen, S. Tian, Rachel Zahigian, Alexandra G Cornell, Susanna A McColley> ;The Lancet. Respiratory Medicine. 2021 May 6
• 35 citations
  Soft, skin-interfaced sweat stickers for cystic fibrosis diagnosis and management
  Tyler R. Ray, Maja Ivanovic, Paul M. Curtis, Daniel Franklin, Kerem Guventurk, William J. Jeang, Joseph Chafetz, Hannah Gaertner, Grace Young, Steve Rebollo, Jeffrey B...> ;Science Translational Medicine. 2021 Mar 31
• 118 citations
  A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
  Edith T. Zemanick, Jennifer L. Taylor-Cousar, Jane Davies, Ronald L. Gibson, Marcus A. Mall, Edward F. McKone, Paul McNally, Bonnie W. Ramsey, Jonathan H. Rayment, Ste...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Jun 25
• 76 citations
  Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
  Meghan E. McGarry, Susanna A. McColley> ;Pediatric Pulmonology. 2021 Jan 20
• 2 citations
  Preferences for Disclosing Adverse Childhood Experiences for Children and Adults with Cystic Fibrosis
  Wadsworth A. Williams, Manu Jain, Theresa A. Laguna, Susanna A. McColley> ;Pediatric Pulmonology. 2021 Jan 12
• Join now to see all

Lectures

• Section on Pediatric Pulmonology and Sleep Medicine Program 
  National Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/28/2019